mexiletine hydrochloride 250 mg

INDICATIONS AND USAGE Mexiletine hydrochloride capsules are indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgement of the physician, are life-threatening. Because of the proarrhythmic effects of mexiletine, its use with lesser arrhythmias is generally not recommended. Treatment of patients with asymptomatic ventricular premature contractions should be avoided. Initiation of mexiletine treatment, as with other antiarrhythmic agents used to treat life-threatening arrhythmias, should be carried out in the hospital. Antiarrhythmic drugs have not been shown to enhance survival in patients with ventricular arrhythmias.

chartwell rx, llc

FDA Reported Adverse Reactions
`[1] fatigue` `[2] drug ineffective` `[3] pain` `[4] dyspnoea` `[5] off label use` `[6] nausea` `[7] diarrhoea` `[8] arthralgia` `[9] pyrexia` `[10] headache`

5 months ago

CAPSULE ORANGE 250

HOW SUPPLIED

MEXILETINE HYDROCHLORIDE capsules, USP are supplied in bottles of 90 hard gelatin capsules containing 250 mg of

MEXILETINE HYDROCHLORIDE, USP:

MEXILETINE HYDROCHLORIDE capsules, USP, 250 mg have an orange body and green cap with the marking "250" in black ink on the cap. capsules contain white or almost white powder. (NDC 62135-785-90). Store at 25°C (77°F); excursions permitted to 15–30°C (59–86°F) [see USP Controlled Room Temperature]. Dispense with a child-resistant closure (as required). Rx Only Manufactured by: Rivopharm S.A. 6928, Manno, Switzerland Manufactured for: Chartwell RX, LLC. Congers, NY 10920 L71750 Rev. 10/2023

More pills like CAPSULE 250

Related Pills

mexiletine hydrochloride 250 mg capsule

lannett company, inc.

Doxepin Hydrochloride Doxepin Hydrochloride 50 MG Oral Capsule

Mylan Institutional Inc.

mysoline primidone tablet

valeant pharmaceuticals north america

chlorzoxazone tablet

solubiomix

divalproex sodium tablet delayed release

upsher-smith laboratories, llc

Escitalopram 10 mg

exelan pharmaceuticals inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site